Funding
← Back to your selection

Catalio Capital Management

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Sep 17, 2026
Rounds participated in
3
Confirmed lead rounds
1
All roles disclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$526M
3 disclosed · full round size, not this investor’s share

By stage

Series C+3

By primary sector

Biotech3

By country

United States2
United Kingdom1

Rounds

3 in this selection
BigHat Biosciences

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

$75MSeries C
Participant
Basecamp Research

Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines.

$140MSeries C
Participant
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Lead